Alta Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.4M Sell
65,914
-4,852
-7% -$2.63M 2.51% 12
2025
Q4
$41M Sell
70,766
-16,022
-18% -$9.06M 2.73% 12
2025
Q3
$42.1M Sell
86,788
-2,545
-3% -$1.18M 2.34% 16
2025
Q2
$36.2M Buy
89,333
+4,208
+5% +$1.76M 2.06% 21
2025
Q1
$42.4M Sell
85,125
-2,028
-2% -$1.1M 2.75% 15
2024
Q4
$45.3M Sell
87,153
-898
-1% -$494K 2.7% 16
2024
Q3
$54.5M Buy
88,051
+2,204
+3% +$1.3M 3.24% 10
2024
Q2
$47.5M Sell
85,847
-3,702
-4% -$2.12M 2.99% 12
2024
Q1
$52M Buy
89,549
+104
+0.1% +$58.4K 3.21% 9
2023
Q4
$47.5M Buy
89,445
+1,635
+2% +$791K 3.07% 11
2023
Q3
$44.4M Sell
87,810
-476
-0.5% -$254K 3.2% 12
2023
Q2
$46.1M Buy
88,286
+4,307
+5% +$2.32M 3.16% 8
2023
Q1
$48.4M Sell
83,979
-4,845
-5% -$2.73M 3.56% 5
2022
Q4
$48.9M Sell
88,824
-5,201
-6% -$2.76M 3.74% 6
2022
Q3
$47.7M Sell
94,025
-599
-0.6% -$335K 3.73% 4
2022
Q2
$51.4M Sell
94,624
-14,898
-14% -$8.2M 3.77% 4
2022
Q1
$64.7M Sell
109,522
-555
-0.5% -$319K 3.78% 5
2021
Q4
$73.4M Sell
110,077
-2,098
-2% -$1.31M 3.8% 4
2021
Q3
$64.1M Sell
112,175
-110,357
-50% -$60.6M 3.62% 5
2021
Q2
$112M Buy
222,532
+221
+0.1% +$104K 3.23% 7
2021
Q1
$101M Buy
222,311
+98,232
+79% +$46.9M 3.1% 11
2020
Q4
$57.8M Sell
124,079
-127,492
-51% -$59.8M 3.26% 8
2020
Q3
$111M Sell
251,571
-62,637
-20% -$25.9M 3.54% 7
2020
Q2
$114M Sell
314,208
-15,629
-5% -$5.24M 3.99% 5
2020
Q1
$93.5M Buy
329,837
+161,119
+95% +$50.8M 4.04% 5
2019
Q4
$54.8M Sell
168,718
-3,307
-2% -$1M 3.57% 7
2019
Q3
$50.1M Sell
172,025
-42,051
-20% -$12M 3.47% 7
2019
Q2
$62.9M Sell
214,076
-264
-0.1% -$72.7K 3.51% 7
2019
Q1
$58.7M Buy
214,340
+58,968
+38% +$14.7M 3.45% 6
2018
Q4
$34.8M Sell
155,372
-122
-0.1% -$28.6K 2.25% 20
2018
Q3
$38M Sell
155,494
-43,655
-22% -$10M 2.11% 22
2018
Q2
$41.3M Sell
199,149
-3,756
-2% -$797K 2.54% 16
2018
Q1
$41.9M Sell
202,905
-5,599
-3% -$1.18M 2.6% 18
2017
Q4
$39.6M Sell
208,504
-5,864
-3% -$1.12M 2.49% 19
2017
Q3
$40.6M Sell
214,368
-9,228
-4% -$1.67M 2.62% 18
2017
Q2
$39M Sell
223,596
-771
-0.3% -$130K 2.64% 17
2017
Q1
$34.5M Buy
224,367
+359
+0.2% +$54.9K 2.31% 21
2016
Q4
$31.6M Sell
224,008
-58,343
-21% -$8.6M 2.27% 21
2016
Q3
$44.9M Sell
282,351
-3,262
-1% -$503K 2.8% 13
2016
Q2
$42.2M Buy
285,613
+941
+0.3% +$139K 2.61% 18
2016
Q1
$40.3M Buy
284,672
+7,505
+3% +$1.01M 2.49% 20
2015
Q4
$39.3M Buy
277,167
+5,490
+2% +$732K 3.17% 9
2015
Q3
$33.2M Buy
271,677
+4,098
+2% +$534K 2.82% 15
2015
Q2
$34.7M Buy
267,579
+19,621
+8% +$2.56M 2.85% 11
2015
Q1
$33.3M Sell
247,958
-18,713
-7% -$2.41M 2.83% 12
2014
Q4
$33.4M Buy
266,671
+34,173
+15% +$4.16M 2.79% 13
2014
Q3
$28.3M Sell
232,498
-2,301
-1% -$280K 2.62% 17
2014
Q2
$27.7M Buy
234,799
+4,139
+2% +$487K 2.55% 15
2014
Q1
$27.7M Buy
230,660
+3,560
+2% +$423K 2.69% 10
2013
Q4
$25.3M Buy
227,100
+5,007
+2% +$498K 2.6% 15
2013
Q3
$20.5M Buy
222,093
+3,323
+2% +$301K 2.46% 19
2013
Q2
$18.5M Buy
+218,770
New +$18.2M 2.5% 20

Other funds holding TMO

Alta Capital Management's TMO Position: Q1 2026 in Review

Alta Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 6.9% in Q1 2026, selling an estimated $2.63M and leaving 65,914 shares worth $32.4M. The position accounts for 2.51% of the portfolio, ranked #12.

Alta Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $114M in Q2 2020. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Alta Capital Management held 65,914 shares of Thermo Fisher Scientific worth $32.4M as of Q1 2026.
  • Alta Capital Management sold 4,852 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.63M.
  • Thermo Fisher Scientific made up 2.51% of Alta Capital Management's portfolio in Q1 2026, its #12 holding.
  • Alta Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Alta Capital Management's Thermo Fisher Scientific position peaked at $114M in Q2 2020.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Alta Capital Management's 13F filing for Q1 2026, filed 11 May 2026.